3 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Identification of a Potent and Selective GPR4 Antagonist as a Drug Lead for the Treatment of Myocardial Infarction.
Hokkaido University
Development of Selective, Orally Active GPR4 Antagonists with Modulatory Effects on Nociception, Inflammation, and Angiogenesis.
Novartis Institutes For Biomedical Research
Small molecule inhibitors of GPCR GPR68 and related receptors for treating cancer, glioblastoma, and other indications
University of Maryland, Baltimore